Results 11 to 20 of about 298,746 (351)

Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase [PDF]

, 2018
Hepatitis C virus (HCV) represents a fundamental issue for public health, with long term evolution and the gradual appearance of several complications and associated pathologies.
Boldeanu, Lidia, Boldeanu, Mihail V., Caragea, Daniel C., Ciurea, Marius E., Ciurea, Tudorel, Forțofoiu, Maria, Forțofoiu, Mircea C., Popescu-Drigă, Mircea, Pădureanu, Vlad, Rogoveanu, Ion, Streba, Costin, Săndulescu, Larisa, Vere, Cristin C.   +12 more
core   +6 more sources

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

New England Journal of Medicine, 2020
BACKGROUND More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two ...
M. Walsh, P. Merkel, C. Peh, W. Szpirt, X. Puéchal, S. Fujimoto, C. Hawley, N. Khalidi, O. Flossmann, R. Wald, L. Girard, A. Levin, G. Gregorini, L. Harper, W. Clark, C. Pagnoux, U. Specks, L. Smyth, V. Tesar, T. Ito-Ihara, J. D. de Zoysa, W. Szczeklik, L. Flores-Suárez, S. Carette, L. Guillevin, C. Pusey, A. Casian, B. Brezina, Andrea Mazzetti, Carol A. McAlear, E. Broadhurst, DM Reidlinger, S. Mehta, N. Ives, D. Jayne   +34 more
semanticscholar   +1 more source

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

Trials, 2023
Background Sequential B cell-targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms.
Mark E. McClure, Seerapani Gopaluni, James Wason, Robert B. Henderson, Andre Van Maurik, Caroline C.O. Savage, Charles D. Pusey, Alan D. Salama, Paul A. Lyons, Jacinta Lee, Kim Mynard, David R. Jayne, Rachel B. Jones, on behalf the COMBIVAS investigators   +13 more
doaj   +1 more source

IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers

Frontiers in Immunology, 2022
Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common systemic vasculitis in children, characterized by diverse clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to ...
Liyun Xu, Yongzhen Li, Xiaochuan Wu
semanticscholar   +1 more source

Introduction to the PANLAR Guidelines: Giant Cell Arteritis

Global Rheumatology, 2022
Introduction to the PANLAR Guidelines: Giant Cell Arteritis Dr. Sebastián Unizony describes how the process of construction and consolidation of this document by a team of experts was.
Sebastian Unizony
doaj   +1 more source

ANCA-Associated Vasculitis: Core Curriculum 2020.

American Journal of Kidney Diseases, 2020
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of disorders characterized by inflammation and destruction of small- and medium-sized blood vessels and the presence of circulating ANCA.
D. Geetha, J. A. Jefferson
semanticscholar   +1 more source

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2021
Importance The current standard induction therapy for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis is the combination of high-dose glucocorticoids and cyclophosphamide or rituximab.
S. Furuta, D. Nakagomi, Yoshihisa Kobayashi, M. Hiraguri, T. Sugiyama, K. Amano, T. Umibe, H. Kono, K. Kurasawa, Y. Kita, R. Matsumura, Y. Kaneko, K. Ninagawa, K. Hiromura, S. Kagami, Y. Inaba, H. Hanaoka, K. Ikeda, H. Nakajima   +18 more
semanticscholar   +1 more source

Netting neutrophils in autoimmune small-vessel vasculitis

Nature Medicine, 2009
Kai Kessenbrock, Volker Brinkmann
exaly   +2 more sources

Immune-Complex Allergic Vasculitis in Association with the Immune-Complex Allergic Vasculitis in Association with the Development of Transverse Myelitis: A Case Report [PDF]

, 1996
A severe vasculitis, probably therapy related, in a sixty-four-year-old man being treated for possible subacute bacterial endocarditis, was associated with the development of transverse myelitis.
Günter Pilz, Lie JT, Paine RS, Sigrid Nikol, Tanya Y. Huehns, Wolfgang von Scheidt   +5 more
core   +1 more source

ANCA-Associated Vasculitis: An Update

Journal of Clinical Medicine, 2021
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group of small vessel vasculitides characterized by granulomatous and neutrophilic tissue inflammation, often associated with the production of antibodies that target ...
S. Almaani, L. Fussner, S. Brodsky, Alexa S Meara, D. Jayne   +4 more
semanticscholar   +1 more source